Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Atsushi Sakamoto , Anne Cornelissen , Yu Sato , et al Added: 2 years ago

Vascular Disease and Surgery
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:29: PACMAN AMI:… View more

Anticoagulation

Vascular Disease and Surgery
Laura Redman
Job title: MBChB, FCS(SA), MMED, Cert Vascular Surgery
Personal History Dr Laura Anne Redman is a qualified General Surgeon and Vascular Surgeon based in Cape Town, South Africa. Outside of work, she enjoys playing the piano, sketching, doing sculptures, running and swimming.7 Academic History In 2014, Dr Redman graduated from the University of KwaZulu-Natal with a Masters of Medicine (MMED), which was focused on the thoracic… View more
Role of Intracoronary Imaging in Acute Coronary Syndromes
Author(s): Gregory Petrossian , Denizhan Ozdemir , Keyvan Karimi Galougahi , et al Added: 1 year ago

Imaging & Diagnostics

MI/ACS
An Approach to Non-left Main Bifurcation Lesions
Author(s): Ali Nazmi Calik , F Aaysha Cader , Erik Rafflenbeul , et al Added: 8 months ago

Intervention
Calcified Lesion Assessment and Intervention in Complex Percutaneous Coronary Intervention: Overview of Angioplasty, Atherectomy, and Lithotripsy
Author(s): Alexander G Truesdell , Matheen A Khuddus , Sara C Martinez , et al Added: 3 years ago
“When you fail to prepare, you’re preparing to fail.” – Coach John Wooden Ongoing technological and procedural innovations increasingly permit the safe and effective performance of ever more high-risk and complex percutaneous coronary interventions (PCI) in the modern cardiac catheterization laboratory. Anatomic characteristics of higher risk include unprotected distal left main stenosis,… View more

Intervention
Author(s): Raoul Bonan , Anita W Asgar Added: 3 years ago
Coronary angioplasty has revolutionized the treatment of coronary artery disease. Over the past two decades the field has seen numerous innovations in an attempt to perfect the percutaneous management of coronary atherosclerotic disease. The development of coronary stenting was a major advance in preventing elastic recoil and treating dissections following balloon angioplasty.1 Unfortunately,… View more

Intervention
Author(s): Jakub Podolec , Lukasz Niewiara Added: 3 years ago
Atherosclerosis is the primary cause of coronary artery disease morbidity and mortality worldwide.1 Low-density lipoprotein cholesterol (LDL-C)- lowering therapies have already become one of the most important in the prevention of atherosclerosis complications.2 Evolocumab is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) and thus significantly… View more

Prevention & Chronic Conditions
ESC 23: Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the third day of ESC Congress 2023. New data releases covered in detail include: ILUMIEN IV OCTIVUS OCTOBER OCT Vs IVUS Vs Angiography Guidance Meta-analysis MULTISTARS-AMI ATTRibute Recorded on-site at ESC Congress 2023, Amsterdam. Editors: Mirjam Boros… View more

Intervention
ACC 22: PACMAN-AMI Shows Reduced Plaque Regression in AMI Patients Treated with Alirocumab
Author(s): Lorenz Räber Added: 2 years ago
In this late-breaking interview focusing on the PACMAN-AMI Trial, Prof Lorenz Räber (Bern University Hospital, CH) reveals that the use of alirocumab reduced coronary plaque regression in patients with acute myocardial infarction (AMI) (NCT03067844). Originally presented by Prof Raber at ACC.22, these findings suggest that alirocumab, on top of high-intensity statin therapy, may be an effective… View more

Prevention & Chronic Conditions